Study of SGR-1505 in Mature B-Cell Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
- Status
- RECRUITING
- Phase
- N/A
Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
- Status
- RECRUITING
- Phase
- N/A
Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor Burden
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
- Status
- RECRUITING
- Phase
- N/A
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL
- Status
- WITHDRAWN
- Phase
- PHASE1
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
- Status
- COMPLETED
- Phase
- NA
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3